Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 4606 AL 4620

Symptomatic treatments in Alzheimer's disease in 2016: a study from Memory centers in France

Hommet C, Novella JL, Auriacombe S, Vercelletto M, Berrut G, Belliard S, Desmidt T, Ceccaldi M.

Geriatr Psychol Neuropsychiatr Vieil. 2016 Sep 1;14(3):274-86. doi: 10.1684/pnv.2016.0629.

Pharmacological treatments of behavioral and psychological symptoms of dementia in Alzheimer's disease: role of acetylcholinesterase inhibitors and memantine

Desmidt T, Hommet C, Camus V.

Geriatr Psychol Neuropsychiatr Vieil. 2016 Sep 1;14(3):300-6. doi: 10.1684/pnv.2016.0621.

Recommended cognitive outcomes in preclinical Alzheimer's disease: Consensus statement from the European Prevention of Alzheimer's Dementia project

Ritchie K, Ropacki M, Albala B, Harrison J, Kaye J, Kramer J, Randolph C, Ritchie CW.

Alzheimers Dement. 2017 Feb;13(2):186-195. doi: 10.1016/j.jalz.2016.07.154. Epub 2016 Oct 1.

Evaluating the Role of Hormone Therapy in Postmenopausal Women with Alzheimer's Disease

Osmanovic-Barilar J, Salkovic-Petrisi M.

Drugs Aging. 2016 Nov;33(11):787-808. doi: 10.1007/s40266-016-0407-9.

Multiple Targets for the Management of Alzheimer's Disease

Ahmad SS, Akhtar S, Jamal QM, Rizvi SM, Kamal MA, Khan MK, Siddiqui MH.

CNS Neurol Disord Drug Targets. 2016;15(10):1279-1289. doi: 10.2174/1871527315666161003165855.

ABT-126 monotherapy in mild-to-moderate Alzheimer's dementia: randomized double-blind, placebo and active controlled adaptive trial and open-label extension

Gault LM, Lenz RA, Ritchie CW, Meier A, Othman AA, Tang Q, Berry S, Pritchett Y, Robieson WZ.

Alzheimers Res Ther. 2016 Oct 18;8(1):44. doi: 10.1186/s13195-016-0210-1.

A fixed-dose combination of memantine extended-release and donepezil in the treatment of moderate-to-severe Alzheimer's disease

Deardorff WJ, Grossberg GT.

Drug Des Devel Ther. 2016 Oct 3;10:3267-3279. doi: 10.2147/DDDT.S86463. eCollection 2016.

Effect of concomitant use of memantine on mortality and efficacy outcomes of galantamine-treated patients with Alzheimer's disease: post-hoc analysis of a randomized placebo-controlled study

Hager K, Baseman AS, Nye JS, Brashear HR, Han J, Sano M, Davis B, Richards HM.

Alzheimers Res Ther. 2016 Nov 15;8(1):47. doi: 10.1186/s13195-016-0214-x.

Flashbulb memories of Paris attacks: Recall of these events and subjective reliving of these memories in a case with Alzheimer disease

El Haj M, Gandolphe MC, Wawrziczny E, Antoine P.

Medicine (Baltimore). 2016 Nov;95(46):e5448. doi: 10.1097/MD.0000000000005448.

Alzheimer's disease: expedition into the unknown

The Lancet.

Lancet. 2016 Dec 3;388(10061):2713. doi: 10.1016/S0140-6736(16)32457-6. Epub 2016 Dec 2.

Effect of galantamine on attention in patients with Alzheimer's disease combined with cerebrovascular disease

Park JJ, Choi SH, Kim S, Lee AY, Moon SY, Lee JH, Kwon JC, Park KW, Ku BD, Han HJ, Kim EJ, Shim YS.

Geriatr Gerontol Int. 2017 Oct;17(10):1661-1666. doi: 10.1111/ggi.12934. Epub 2016 Dec 9.

Molecular Diagnostics of Ageing and Tackling Age-related Disease

Timmons JA.

Trends Pharmacol Sci. 2017 Jan;38(1):67-80. doi: 10.1016/j.tips.2016.11.005. Epub 2016 Dec 12.

Special Issue: "Molecules against Alzheimer"

Decker M, Muñoz-Torrero D.

Molecules. 2016 Dec 16;21(12):1736. doi: 10.3390/molecules21121736.

Caregiver Preference and Treatment Compliance in Patients with Mild-to-Moderate Alzheimer's Disease in South Korea: RECAP Study Results

Lee KJ, Cho SJ, Kim BC, Park M, Lee JH.

Adv Ther. 2017 Feb;34(2):481-494. doi: 10.1007/s12325-016-0465-8. Epub 2016 Dec 20.

Alzheimer's Disease Risk and Progression: The Role of Nutritional Supplements and their Effect on Drug Therapy Outcome

Giulietti A, Vignini A, Nanetti L, Mazzanti L, Di Primio R, Salvolini E.

Curr Neuropharmacol. 2016;14(2):177-90. doi: 10.2174/1570159x13666150928155321.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias